The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lynch Samuel Eugene since 2006.
The trader's CIK number is 1362148.
At the time of the last reporting, Lynch Samuel Eugene was the President and CEO of Biomimetic Therapeutics, Inc.. (stock ticker symbol BMTI).
Also see all insider trading activities at Biomimetic Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | BMTI | 0 | $0 | 0 | $0 | 221,000 | $613,275 |
| 2012 | BMTI | 83,150 | $199,438 | 0 | $0 | 0 | $0 |
| 2011 | BMTI | 13,000 | $101,725 | 0 | $0 | 0 | $0 |
| 2010 | BMTI | 0 | $0 | 0 | $0 | 26,250 | $95,287 |
| 2009 | BMTI | 0 | $0 | 153,500 | $1,654,116 | 0 | $0 |
| 2008 | BMTI | 5,400 | $48,227 | 0 | $0 | 77,250 | $274,237 |
| 2007 | BMTI | 0 | $0 | 236,239 | $4,051,498 | 0 | $0 |
| 2006 | BMTI | 12,500 | $100,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | GRNB | 1,710 | $4,512 | 0 | $0 | 0 | $0 |
1. Biomimetic Therapeutics, Inc. (BMTI)
2. Greene County Bancshares Inc (GRNB)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-03-01 | BMTI | Option Ex | 221,000 | 2.77 | 613,275 |
| 2012-03-29 | BMTI | Buy | 30,638 | 2.38 | 72,887 |
| 2012-03-30 | BMTI | Buy | 39,362 | 2.43 | 95,649 |
| 2012-03-23 | BMTI | Buy | 13,150 | 2.35 | 30,902 |
| 2011-05-18 | BMTI | Buy | 13,000 | 7.83 | 101,725 |
| 2010-12-30 | BMTI | Option Ex | 26,250 | 3.63 | 95,287 |
| 2009-12-28 | BMTI | Sale | 3,000 | 11.56 | 34,680 |
| 2009-12-29 | BMTI | Sale | 3,000 | 11.29 | 33,870 |
| 2009-12-14 | BMTI | Sale | 3,000 | 12.32 | 36,960 |
| 2009-12-15 | BMTI | Sale | 3,000 | 12.03 | 36,090 |
| 2009-12-02 | BMTI | Sale | 3,000 | 10.94 | 32,820 |
| 2009-12-03 | BMTI | Sale | 3,000 | 11.24 | 33,720 |
| 2009-11-16 | BMTI | Sale | 3,000 | 11.80 | 35,400 |
| 2009-11-17 | BMTI | Sale | 3,000 | 11.64 | 34,920 |
| 2009-11-05 | BMTI | Sale | 3,000 | 11.70 | 35,100 |
| 2009-11-04 | BMTI | Sale | 3,000 | 11.63 | 34,890 |
| 2009-10-20 | BMTI | Sale | 4,500 | 14.21 | 63,967 |
| 2009-10-21 | BMTI | Sale | 4,500 | 13.85 | 62,325 |
| 2009-10-05 | BMTI | Sale | 3,000 | 11.51 | 34,515 |
| 2009-10-06 | BMTI | Sale | 4,500 | 12.57 | 56,556 |
| 2009-09-23 | BMTI | Sale | 4,500 | 13.08 | 58,864 |
| 2009-09-24 | BMTI | Sale | 4,500 | 12.98 | 58,432 |
| 2009-09-09 | BMTI | Sale | 3,000 | 12.01 | 36,018 |
| 2009-09-10 | BMTI | Sale | 3,000 | 11.99 | 35,982 |
| 2009-08-25 | BMTI | Sale | 3,000 | 11.72 | 35,151 |
| 2009-08-26 | BMTI | Sale | 3,000 | 11.47 | 34,404 |
| 2009-08-13 | BMTI | Sale | 3,000 | 10.79 | 32,376 |
| 2009-08-12 | BMTI | Sale | 3,000 | 10.85 | 32,541 |
| 2009-07-30 | BMTI | Sale | 3,000 | 10.09 | 30,272 |
| 2009-07-29 | BMTI | Sale | 3,000 | 9.85 | 29,535 |
| 2009-07-16 | BMTI | Sale | 3,000 | 9.88 | 29,625 |
| 2009-07-17 | BMTI | Sale | 3,000 | 9.78 | 29,339 |
| 2009-07-01 | BMTI | Sale | 3,000 | 9.37 | 28,095 |
| 2009-06-30 | BMTI | Sale | 3,000 | 9.28 | 27,852 |
| 2009-06-16 | BMTI | Sale | 3,000 | 9.00 | 27,000 |
| 2009-06-17 | BMTI | Sale | 3,000 | 9.03 | 27,078 |
| 2009-06-03 | BMTI | Sale | 3,000 | 9.04 | 27,135 |
| 2009-06-04 | BMTI | Sale | 3,000 | 9.07 | 27,204 |
| 2009-01-29 | BMTI | Sale | 50,000 | 9.63 | 481,400 |
| 2008-10-27 | BMTI | Option Ex | 77,250 | 3.55 | 274,237 |
| 2008-03-28 | BMTI | Buy | 5,400 | 8.93 | 48,227 |
| 2007-02-14 | BMTI | Sale | 236,239 | 17.15 | 4,051,498 |
| 2006-05-12 | BMTI | Buy | 12,500 | 8.00 | 100,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-06-30 | GRNB | Buy | 1,518 | 2.62 | 3,977 |
| 2011-04-12 | GRNB | Buy | 192 | 2.79 | 535 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lynch Samuel Eugene (President and CEO of Biomimetic Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.